2019
DOI: 10.3389/fbioe.2019.00238
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of an Amphiphilic Phosphonated Calixarene Carrier Loaded With Carboplatin and Paclitaxel: A Preliminary Study to Treat Colon Cancer in vitro and in vivo

Abstract: The inadequacy of available detection methods and a naturally aggressive progression have made colon cancer the third most common type of cancer, accounting for ~10% of all cancer cases. The heterogeneity and genomic instability of colon cancer tumors make current treatments unsatisfactory. This study evaluated a novel nanoscale delivery platform comprising phosphonated calixarenes (P4C6) co-loaded with paclitaxel (PTX) and carboplatin (CPT). The nanoparticles showed average hydrodynamic sizes of 84 ± 8 nm for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(11 citation statements)
references
References 57 publications
1
10
0
Order By: Relevance
“…On the other hand, testing H/ p -SC6 nanocapsules on HSF noncancer cells confirmed their biocompatibility compared to free harmala seed fraction. The previous studies reported the ability of different host molecules to encapsulate anticancer drugs and selectively deliver them to cancer cells with minimal toxic effects on normal cells. ,, , These results agree with the in vitro release study demonstrating the pH-triggered release of the HARF from the self-assembled H/ p -SC6 nanocapsules. Cancerous cells have an acidic pH of 5.7, normal cells possess a pH of 7.4, whereas late endosomes and lysosomes have pH values of 4.5–5.5.…”
Section: Results and Discussionsupporting
confidence: 86%
“…On the other hand, testing H/ p -SC6 nanocapsules on HSF noncancer cells confirmed their biocompatibility compared to free harmala seed fraction. The previous studies reported the ability of different host molecules to encapsulate anticancer drugs and selectively deliver them to cancer cells with minimal toxic effects on normal cells. ,, , These results agree with the in vitro release study demonstrating the pH-triggered release of the HARF from the self-assembled H/ p -SC6 nanocapsules. Cancerous cells have an acidic pH of 5.7, normal cells possess a pH of 7.4, whereas late endosomes and lysosomes have pH values of 4.5–5.5.…”
Section: Results and Discussionsupporting
confidence: 86%
“…Another limitation of PTX is its poor solubility in water [ 65 ]. To overcome these problems, various studies demonstrate that efficacy and safety are improved when PTX is encapsulated in calixarene molecules [ 66 , 67 ]. For this purpose, a tetra-hexyloxy- p -sulfonate calix [4] arene (SC4–C6) amphiphilic derivate was synthesized using a thin-film sonication method.…”
Section: Application Of Calixarene On Cancer Therapymentioning
confidence: 99%
“…This formulation mediates a synergistic effect and avoid side effects. The effects of this macro-complex have been studied on human colon cancer cell lines (HT-29 cells and Caco-2 cells) showing greater growth inhibition compared to free drugs [ 67 ]. The combination of carboplatin and paclitaxel was found to be effective for the treatment of ovarian cancer.…”
Section: Application Of Calixarene On Cancer Therapymentioning
confidence: 99%
“…The use of calixarenes as a macrocyclic component is particularly attractive due to the possibility of modification by various functional groups on both sides of the macrocyclic platform. Moreover, calixarenes are capable of forming complexes with various ions and small organic molecules, which can enter the aromatic cavity of the calixarene framework. The guest molecules can also be bonded by calixarene substituents located outside the macrocyclic cavity. Sulfonated calix[4]­arenes typically form supraamphiphiles with cationic surfactant molecules due to electrostatic interactions. ,,, The complexation between the surfactant and the macrocycle in this case leads to a decrease in the critical aggregation concentration compared of the individual components.…”
Section: Introductionmentioning
confidence: 99%
“…For example, the attachment of cisplatin to a calixarene scaffold increases anticancer activity . Various macrocyclic compounds are also able to bind platinum preparations into the intramolecular cavity using supramolecular interactions that reduce its toxicity and protect the substance from decomposition. , Liposomal and micellar cisplatin compositions can also solve the problem of high toxicity. A platinum drug delivery platform was developed using covalent conjugation and coordination-driven self-assembly .…”
Section: Introductionmentioning
confidence: 99%